Altimmune, Inc. (ALT) Tops Q1 EPS by 10c

Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.40), $0.10 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Exyn Technologies, Inc. (EXYN) Reports Q2 Loss of $1.55
• Jaguar Health (JAGX) Tops Q2 EPS by 3647c